{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["autocrine motility factor receptor (AMFR)", "bioinformatics", "cancer", "drug resistance", "microarray", "pharmacogenomics", "phytotherapy", "triterpene"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29867487", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "15"}], "Language": ["eng"], "ELocationID": ["481", "10.3389/fphar.2018.00481"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2018"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).", "Pagination": {"StartPage": "481", "MedlinePgn": "481"}, "Abstract": {"AbstractText": ["Betulinic acid (BetA) is a naturally occurring pentacyclic triterpene isolated from the outer bark of white-barked birch trees and many other medicinal plants. Here, we studied betulinic acid's cytotoxic activity against drug-resistant tumor cell lines. P-glycoprotein (<i>MDR1/ABCB1</i>) and BCRP (<i>ABCG2</i>) are known ATP-binding cassette (ABC) drug transporters that mediating MDR. ABCB5 is a close relative to ABCB1, which also mediates MDR. Constitutive activation of the EGF receptor is tightly linked to the development of chemotherapeutic resistance. BetA inhibited P-gp, BCRP, ABCB5 and mutation activated EGFR overexpressing cells with similar efficacy as their drug-sensitive parental counterparts. Furthermore, the mRNA expressions of ABCB1, BCRP, ABCB5 and EGFR were not related to the 50% inhibition concentrations (IC<sub>50</sub>) for BetA in a panel of 60 cell lines of the National Cancer Institute (NCI), USA. In addition to well-established MDR mechanisms, we attempted to identify other molecular mechanisms that play a role in mediating BetA's cytotoxic activity. For this reason, we performed COMPARE and hierarchical cluster analyses of the transcriptome-wide microarray-based mRNA expression of the NCI cell lines panel. Various genes significantly correlating to BetA's activity were involved in different biological processes, e.g., cell cycle regulation, microtubule formation, signal transduction, transcriptional regulation, chromatin remodeling, cell adhesion, tumor suppression, ubiquitination and proteasome degradation. Immunoblotting and <i>in silico</i> analyses revealed that the inhibition of AMFR activity might be one of the mechanisms for BetA to overcome MDR phenotypes. In conclusion, BetA may have therapeutic potential for the treatment of refractory tumors."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany."}], "LastName": "Saeed", "ForeName": "Mohamed E M", "Initials": "MEM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany."}], "LastName": "Mahmoud", "ForeName": "Nuha", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chemotherapy, Faculty of Pharmacy, Keio University, Tokyo, Japan."}], "LastName": "Sugimoto", "ForeName": "Yoshikazu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical and Clinical Affairs Phytomedicines, Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, Darmstadt, Germany."}], "LastName": "Abdel-Aziz", "ForeName": "Heba", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Arteaga C. L. (2002). Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl. 4), 31\u201339. 10.1634/theoncologist.7-suppl_4-31", "ArticleIdList": ["10.1634/theoncologist.7-suppl_4-31", "12202786"]}, {"Citation": "Asghar U., Witkiewicz A. K., Turner N. C., Knudsen E. S. (2015). The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat. Rev. Drug Discov. 14, 130\u2013146. 10.1038/nrd4504", "ArticleIdList": ["10.1038/nrd4504", "PMC4480421", "25633797"]}, {"Citation": "Chandramu C., Manohar R. D., Krupadanam D. G., Dashavantha R. V. (2003). Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L. Phytother. Res. 17, 129\u2013134. 10.1002/ptr.1088", "ArticleIdList": ["10.1002/ptr.1088", "12601674"]}, {"Citation": "Chang Y. W., Tseng C. F., Wang M. Y., Chang W. C., Lee C. C., Chen L. T., et al. . (2016). Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer. Oncogene 35, 1517\u20131528. 10.1038/onc.2015.214", "ArticleIdList": ["10.1038/onc.2015.214", "26119938"]}, {"Citation": "Chintharlapalli S., Papineni S., Ramaiah S. K., Safe S. (2007). Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 67, 2816\u20132823. 10.1158/0008-5472.CAN-06-3735", "ArticleIdList": ["10.1158/0008-5472.CAN-06-3735", "17363604"]}, {"Citation": "Cichewicz R. H., Kouzi S. A. (2004). Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 24, 90\u2013114. 10.1002/med.10053", "ArticleIdList": ["10.1002/med.10053", "14595673"]}, {"Citation": "Croce C. M. (2008). Oncogenes and cancer. N. Engl. J. Med. 358, 502\u2013511. 10.1056/NEJMra072367", "ArticleIdList": ["10.1056/NEJMra072367", "18234754"]}, {"Citation": "Damle A. A., Pawar Y. P., Narkar A. A. (2013). Anticancer activity of betulinic acid on MCF-7 tumors in nude mice. Indian J. Exp. Biol. 51, 485\u2013491.", "ArticleIdList": ["23898546"]}, {"Citation": "Doyle L. A., Yang W., Abruzzo L. V., Krogmann T., Gao Y., Rishi A. K., et al. . (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 95, 15665\u201315670. 10.1073/pnas.95.26.15665", "ArticleIdList": ["10.1073/pnas.95.26.15665", "PMC28101", "9861027"]}, {"Citation": "Efferth T., Sauerbrey A., Olbrich A., Gebhart E., Rauch P., Weber H. O., et al. . (2003). Molecular modes of action of artesunate in tumor cell lines. Mol. Pharmacol. 64, 382\u2013394. 10.1124/mol.64.2.382", "ArticleIdList": ["10.1124/mol.64.2.382", "12869643"]}, {"Citation": "Eiznhamer D. A., Xu Z. Q. (2004). Betulinic acid: a promising anticancer candidate. IDrugs 7, 359\u2013373.", "ArticleIdList": ["15057642"]}, {"Citation": "Enwerem N. M., Okogun J. I., Wambebe C. O., Okorie D. A., Akah P. A. (2001). Anthelmintic activity of the stem bark extracts of Berlina grandiflora and one of its active principles, Betulinic acid. Phytomedicine 8, 112\u2013114. 10.1078/0944-7113-00023", "ArticleIdList": ["10.1078/0944-7113-00023", "11315752"]}, {"Citation": "Foo J. B., Saiful Yazan L., Tor Y. S., Wibowo A., Ismail N., How C. W., et al. . (2015). Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway. J. Ethnopharmacol. 166, 270\u2013278. 10.1016/j.jep.2015.03.039", "ArticleIdList": ["10.1016/j.jep.2015.03.039", "25797115"]}, {"Citation": "Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., et al. . (1997). Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 57, 4956\u20134964.", "ArticleIdList": ["9354463"]}, {"Citation": "Fulda S., Jeremias I., Steiner H. H., Pietsch T., Debatin K. M. (1999). Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer 82, 435\u2013441. 10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1", "ArticleIdList": ["10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1", "10399962"]}, {"Citation": "Fulda S., Kroemer G. (2009). Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov. Today 14, 885\u2013890. 10.1016/j.drudis.2009.05.015", "ArticleIdList": ["10.1016/j.drudis.2009.05.015", "19520182"]}, {"Citation": "Fulda S., Scaffidi C., Susin S. A., Krammer P. H., Kroemer G., Peter M. E., et al. . (1998). Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273, 33942\u201333948. 10.1074/jbc.273.51.33942", "ArticleIdList": ["10.1074/jbc.273.51.33942", "9852046"]}, {"Citation": "Gao Y., Shen J., Choy E., Mankin H., Hornicek F., Duan Z. (2017). Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss. Cell. Oncol. 40, 209\u2013218. 10.1007/s13402-017-0316-x", "ArticleIdList": ["10.1007/s13402-017-0316-x", "28243976"]}, {"Citation": "Genovese I., Ilari A., Assaraf Y. G., Fazi F., Colotti G. (2017). Not only P-glycoprotein: amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Drug Resist. Updat. 32, 23\u201346. 10.1016/j.drup.2017.10.003", "ArticleIdList": ["10.1016/j.drup.2017.10.003", "29145976"]}, {"Citation": "Haga A., Funasaka T., Niinaka Y., Raz A., Nagase H. (2003). Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. Int. J. Cancer 107, 707\u2013714. 10.1002/ijc.11449", "ArticleIdList": ["10.1002/ijc.11449", "14566819"]}, {"Citation": "Halwani Y., Kojic L. D., Chan S. K., Phang T. P., Masoudi H., Jones S. J., et al. . (2015). Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases. Am. J. Surg. 209, 884\u2013889. Discussion: 889. 10.1016/j.amjsurg.2015.01.010", "ArticleIdList": ["10.1016/j.amjsurg.2015.01.010", "25852009"]}, {"Citation": "Hsu R. J., Hsu Y. C., Chen S. P., Fu C. L., Yu J. C., Chang F. W., et al. . (2015). The triterpenoids of Hibiscus syriacus induce apoptosis and inhibit cell migration in breast cancer cells. BMC Complement. Altern. Med. 15:65. 10.1186/s12906-015-0592-9", "ArticleIdList": ["10.1186/s12906-015-0592-9", "PMC4410586", "25885960"]}, {"Citation": "Huang H. S., Nagane M., Klingbeil C. K., Lin H., Nishikawa R., Ji X. D., et al. . (1997). The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem. 272, 2927\u20132935. 10.1074/jbc.272.5.2927", "ArticleIdList": ["10.1074/jbc.272.5.2927", "9006938"]}, {"Citation": "Jung G. R., Kim K. J., Choi C. H., Lee T. B., Han S. I., Han H. K., et al. . (2007). Effect of betulinic acid on anticancer drug-resistant colon cancer cells. Basic Clin. Pharmacol. Toxicol. 101, 277\u2013285. 10.1111/j.1742-7843.2007.00115.x", "ArticleIdList": ["10.1111/j.1742-7843.2007.00115.x", "17845510"]}, {"Citation": "Karna E., Szoka L., Palka J. A. (2010). Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Mol. Cell. Biochem. 340, 15\u201320. 10.1007/s11010-010-0395-8", "ArticleIdList": ["10.1007/s11010-010-0395-8", "20174965"]}, {"Citation": "Kawanobe T., Kogure S., Nakamura S., Sato M., Katayama K., Mitsuhashi J., et al. . (2012). Expression of human ABCB5 confers resistance to taxanes and anthracyclines. Biochem. Biophys. Res. Commun. 418, 736\u2013741. 10.1016/j.bbrc.2012.01.090", "ArticleIdList": ["10.1016/j.bbrc.2012.01.090", "22306008"]}, {"Citation": "Kaynak K., Kara M., Oz B., Akgoz B., Sar M., Raz A. (2005). Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas. Acta Chir. Belg. 105, 378\u2013382. 10.1080/00015458.2005.11679740", "ArticleIdList": ["10.1080/00015458.2005.11679740", "16184720"]}, {"Citation": "Kho D. H., Nangia-Makker P., Balan V., Hogan V., Tait L., Wang Y., et al. . (2013). Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells. Cancer Res. 73, 1411\u20131419. 10.1158/0008-5472.CAN-12-2149", "ArticleIdList": ["10.1158/0008-5472.CAN-12-2149", "PMC3577983", "23248119"]}, {"Citation": "Kimmig A., Gekeler V., Neumann M., Frese G., Handgretinger R., Kardos G., et al. . (1990). Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res. 50, 6793\u20136799.", "ArticleIdList": ["1698543"]}, {"Citation": "Kojic L. D., Joshi B., Lajoie P., Le P. U., Cox M. E., Turbin D. A., et al. . (2007). Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells. J. Biol. Chem. 282, 29305\u201329313. 10.1074/jbc.M704069200", "ArticleIdList": ["10.1074/jbc.M704069200", "17690101"]}, {"Citation": "Kuan C. T., Wikstrand C. J., Bigner D. D. (2000). EGFRvIII as a promising target for antibody-based brain tumor therapy. Brain Tumor Pathol. 17, 71\u201378. 10.1007/BF02482738", "ArticleIdList": ["10.1007/BF02482738", "11210174"]}, {"Citation": "Kuete V., Efferth T. (2013). Molecular determinants of cancer cell sensitivity and resistance towards the sesquiterpene farnesol. Pharmazie 68, 608\u2013615. 10.1691/ph.2013.6503", "ArticleIdList": ["10.1691/ph.2013.6503", "23923645"]}, {"Citation": "Li F., Goila-Gaur R., Salzwedel K., Kilgore N. R., Reddick M., Matallana C., et al. . (2003). PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. U.S.A. 100, 13555\u201313560. 10.1073/pnas.2234683100", "ArticleIdList": ["10.1073/pnas.2234683100", "PMC263852", "14573704"]}, {"Citation": "Mayaux J. F., Bousseau A., Pauwels R., Huet T., Henin Y., Dereu N., et al. . (1994). Triterpene derivatives that block entry of human-immunodeficiency-virus type-1 into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 3564\u20133568. 10.1073/pnas.91.9.3564", "ArticleIdList": ["10.1073/pnas.91.9.3564", "PMC43620", "8170948"]}, {"Citation": "Melzig M. F., Bormann H. (1998). Betulinic acid inhibits aminopeptidase N activity. Planta Med. 64, 655\u2013657. 10.1055/s-2006-957542", "ArticleIdList": ["10.1055/s-2006-957542", "9810272"]}, {"Citation": "Monga M., Sausville E. A. (2002). Developmental Therapeutics Program at the NCI: molecular target and drug discovery process. Leukemia 16, 520\u2013526. 10.1038/sj.leu.2402464", "ArticleIdList": ["10.1038/sj.leu.2402464", "11960328"]}, {"Citation": "Nair S. S., Kumar R. (2012). Chromatin remodeling in cancer: a gateway to regulate gene transcription. Mol. Oncol. 6, 611\u2013619. 10.1016/j.molonc.2012.09.005", "ArticleIdList": ["10.1016/j.molonc.2012.09.005", "PMC3538127", "23127546"]}, {"Citation": "Nishikawa R., Ji X. D., Harmon R. C., Lazar C. S., Gill G. N., Cavenee W. K., et al. . (1994). A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. U.S.A. 91, 7727\u20137731. 10.1073/pnas.91.16.7727", "ArticleIdList": ["10.1073/pnas.91.16.7727", "PMC44475", "8052651"]}, {"Citation": "Onishi Y., Tsukada K., Yokota J., Raz A. (2003). Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation. Clin. Exp. Metastasis 20, 51\u201358. 10.1023/A:1022594503657", "ArticleIdList": ["10.1023/A:1022594503657", "12650607"]}, {"Citation": "Pengsuparp T., Cai L., Fong H. H., Kinghorn A. D., Pezzuto J. M., Wani M. C., et al. . (1994). Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1 reverse transcriptase. J. Nat. Prod. 57, 415\u2013418. 10.1021/np50105a017", "ArticleIdList": ["10.1021/np50105a017", "7515410"]}, {"Citation": "Quint\u00e1s-Cardama A., Verstovsek S. (2013). Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin. Cancer Res. 19, 1933\u20131940. 10.1158/1078-0432.CCR-12-0284", "ArticleIdList": ["10.1158/1078-0432.CCR-12-0284", "PMC5021219", "23406773"]}, {"Citation": "Raghuvar Gopal D. V., Narkar A. A., Badrinath Y., Mishra K. P., Joshi D. S. (2005). Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl. Toxicol. Lett. 155, 343\u2013351. 10.1016/j.toxlet.2004.06.015", "ArticleIdList": ["10.1016/j.toxlet.2004.06.015", "15649617"]}, {"Citation": "Saeed M. E., Mahmoud N., Sugimoto Y., Efferth T., Abdel-Aziz H. (2018). Molecular determinants of sensitivity or resistance of cancer cells toward sanguinarine. Front. Pharmacol. 9:136. 10.3389/fphar.2018.00136", "ArticleIdList": ["10.3389/fphar.2018.00136", "PMC5834429", "29535628"]}, {"Citation": "Saha A., Wittmeyer J., Cairns B. R. (2006). Chromatin remodelling: the industrial revolution of DNA around histones. Nat. Rev. Mol. Cell Biol. 7, 437\u2013447. 10.1038/nrm1945", "ArticleIdList": ["10.1038/nrm1945", "16723979"]}, {"Citation": "Sch\u00fchly W., Heilmann J., Calis I., Sticher O. (1999). New triterpenoids with antibacterial activity from Zizyphus joazeiro. Planta Med. 65, 740\u2013743. 10.1055/s-1999-14054", "ArticleIdList": ["10.1055/s-1999-14054", "10630117"]}, {"Citation": "Setzer W. N., Setzer M. C., Bates R. B., Jackes B. R. (2000). Biologically active triterpenoids of Syncarpia glomulifera bark extract from Paluma, north Queensland, Australia. Planta Med. 66, 176\u2013177. 10.1055/s-2000-11129", "ArticleIdList": ["10.1055/s-2000-11129", "10763596"]}, {"Citation": "Shimizu K., Tani M., Watanabe H., Nagamachi Y., Niinaka Y., Shiroishi T., et al. . (1999). The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett. 456, 295\u2013300. 10.1016/S0014-5793(99)00966-7", "ArticleIdList": ["10.1016/S0014-5793(99)00966-7", "10456327"]}, {"Citation": "Shin J., Lee H. J., Jung D. B., Jung J. H., Lee H. J., Lee E. O., et al. . (2011). Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells. PLoS ONE 6:e21492. 10.1371/journal.pone.0021492", "ArticleIdList": ["10.1371/journal.pone.0021492", "PMC3123343", "21731766"]}, {"Citation": "Shinojima N., Tada K., Shiraishi S., Kamiryo T., Kochi M., Nakamura H., et al. . (2003). Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res. 63, 6962\u20136970.", "ArticleIdList": ["14583498"]}, {"Citation": "Siddiqui B. S., Sultana I., Begum S. (2000). Triterpenoidal constituents from Eucalyptus camaldulensis var. obtusa leaves. Phytochemistry 54, 861\u2013865. 10.1016/S0031-9422(00)00058-3", "ArticleIdList": ["10.1016/S0031-9422(00)00058-3", "11014279"]}, {"Citation": "Silletti S., Watanabe H., Hogan V., Nabi I. R., Raz A. (1991). Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res. 51, 3507\u20133511.", "ArticleIdList": ["1647268"]}, {"Citation": "Sun W. L., Lan D., Gan T. Q., Cai Z. W. (2015). Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells. Neoplasma 62, 199\u2013208. 10.4149/neo_2015_025", "ArticleIdList": ["10.4149/neo_2015_025", "25591585"]}, {"Citation": "Tezuka Y., Stampoulis P., Banskota A. H., Awale S., Tran K. Q., Saiki I., et al. . (2000). Constituents of the Vietnamese medicinal plant Orthosiphon stamineus. Chem. Pharm. Bull. 48, 1711\u20131719. 10.1248/cpb.48.1711", "ArticleIdList": ["10.1248/cpb.48.1711", "11086900"]}, {"Citation": "Thomas J. O., Kornberg R. D. (1975). An octamer of histones in chromatin and free in solution. Proc. Natl. Acad. Sci. U.S.A. 72, 2626\u20132630. 10.1073/pnas.72.7.2626", "ArticleIdList": ["10.1073/pnas.72.7.2626", "PMC432822", "241077"]}, {"Citation": "T\u00edm\u00e1r J., R\u00e1s\u00f3 E., D\u00f6me B., Lad\u00e1nyi A., B\u00e1nfalvi T., Gilde K., et al. . (2002). Expression and function of the AMF receptor by human melanoma in experimental and clinical systems. Clin. Exp. Metastasis 19, 225\u2013232. 10.1023/A:1015595708241", "ArticleIdList": ["10.1023/A:1015595708241", "12067203"]}, {"Citation": "Tiwari R., Puthli A., Balakrishnan S., Sapra B. K., Mishra K. P. (2014). Betulinic acid-induced cytotoxicity in human breast tumor cell lines MCF-7 and T47D and its modification by tocopherol. Cancer Invest. 32, 402\u2013408. 10.3109/07357907.2014.933234", "ArticleIdList": ["10.3109/07357907.2014.933234", "25019212"]}, {"Citation": "Tsutsumi S., Gupta S. K., Hogan V., Collard J. G., Raz A. (2002). Activation of small GTPase Rho is required for autocrine motility factor signaling. Cancer Res. 62, 4484\u20134490.", "ArticleIdList": ["12154059"]}, {"Citation": "Ueda K., Cornwell M. M., Gottesman M. M., Pastan I., Roninson I. B., Ling V., et al. . (1986). The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 141, 956\u2013962. 10.1016/S0006-291X(86)80136-X", "ArticleIdList": ["10.1016/S0006-291X(86)80136-X", "2880583"]}, {"Citation": "Wang L., Hou G., Xue L., Li J., Wei P., Xu P. (2010a). Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells. Cancer Invest. 28, 993\u20131003. 10.3109/07357907.2010.483503", "ArticleIdList": ["10.3109/07357907.2010.483503", "20504226"]}, {"Citation": "Wang L., Xue L., Yan H., Li J., Lu Y. (2010b). Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol. Biol. Rep. 37, 1971\u20131977. 10.1007/s11033-009-9645-9", "ArticleIdList": ["10.1007/s11033-009-9645-9", "19649725"]}, {"Citation": "Wang Y., Ma L., Wang C., Sheng G., Feng L., Yin C. (2015). Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells. Int. J. Mol. Med. 36, 627\u2013632. 10.3892/ijmm.2015.2267", "ArticleIdList": ["10.3892/ijmm.2015.2267", "PMC4533783", "26136223"]}, {"Citation": "Woldemichael G. M., Singh M. P., Maiese W. M., Timmermann B. N. (2003). Constituents of antibacterial extract of Caesalpinia paraguariensis Burk. Z. Naturforsch. C. 58, 70\u201375. 10.1515/znc-2003-1-213", "ArticleIdList": ["10.1515/znc-2003-1-213", "12622230"]}, {"Citation": "Yi J. H., Zhang G. L., Li B. G., Chen Y. Z. (2000). Two glycosides from the stem bark of Tetracentron sinense. Phytochemistry 53, 1001\u20131003. 10.1016/S0031-9422(99)00457-4", "ArticleIdList": ["10.1016/S0031-9422(99)00457-4", "10820820"]}]}], "History": [{"Year": "2018", "Month": "1", "Day": "23"}, {"Year": "2018", "Month": "4", "Day": "24"}, {"Year": "2018", "Month": "6", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "5", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["29867487", "PMC5962668", "10.3389/fphar.2018.00481"]}}]}